Effects of thyroxine therapy on bone metabolism in postmenopausal women with hypothyroidism

Acta Obstetricia et Gynecologica Scandinavica

Volumn 75, Issue 9, 1996, Pages 843-848

  Affinito, Pietro ^a,b   Sorrentino, Claudia ^a   Farace, Maria Jussie ^a   Di Carlo, Costantino ^a   Moccia, Gianfranco ^a   Canciello, Pasqualina ^a   Palomba, Stefano ^a   Nappi, Carmine ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Bone metabolism; Menopause; Thyroxine; Treatment of hypothyroidism

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CREATININE; HYDROXYPROLINE; OSTEOCALCIN; THYROTROPIN; THYROXINE;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE METABOLISM; BONE MINERAL; BONE TURNOVER; CALCIUM URINE LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE URINE LEVEL; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYDROXYPROLINE URINE LEVEL; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RADIUS; STATISTICAL ANALYSIS;

EID: 0029839142     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.3109/00016349609054714     Document Type: Article

References (20)

1. Meunier PJ, Bianchi GGS, Eduard CM, Bernard JC, Courprous P, Vignou GE. Bony manifestations of thyrotoxicosis. Orthop Clin North Am 1972; 3: 745-74.
2. Riggs BL, Melton LJ. Involutional osteoporosis. N Engl J Med 1986; 314: 1676-84.
3. Fallon MD, Perry HM III, Bergfeld M, Droke D, Teitelbaum SL, Avioli LV Exogenous hyperthyroidism with osteoporosis. Arch Inter Med 1983; 143: 442-4.
4. Coindre JM, David JP, Riviere L, Goussot JF, Roger P, de Mascarel A et al. Bone loss in hypothyroidism with hormone replacement: a histomorphometric study. Arch Intern Med 1986; 146: 48-53.
5. Ross DS, Neer RM, Ridgway EC, Daniels GH. Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of pituitary-thyroid axis with L-thyroxine. Am J Med 1987; 82: 1167-70.
6. Krolner B, Jorgensen JV, Nielsen SP. Spinal bone mineral content in myxoedema and thyrotoxicosis. Effects of thyroid hormone (s) and antithyroid treatment. Clin Endocrinol (Oxf) 1983; 18: 439-46.
7. Stall GM, Harris S, Sokoll LJ, Dawson-Hughes B. Accelerated bone loss in hypothyroid patients over-treated with L-thyroxine. Ann Internal Med 1990; 113: 265-9.
8. Baran DT. Editorial detrimental skeletal effects ohyrotropin suppressive doses of thyroxine: fact or fantasy? J Clin Endocrinol Metab 1994; 816-7.
9. Franklin JA, Betteridge J, Daykin J, Holder R, Dates GD, Parle JU et al. Long-term thyroxine treatment and bone mineral density. The Lancet 1992; 340: 9-13.
10. Grant DJ, McMurdo MET, Mole PA, Paterson CR, Davies RR. Suppressed TSH levels secondary to thyroxine replacement therapy are not associated with osteoporosis. Clin Endocrinol 1990; 39: 529-33.
11. Ribot C, Tremollieres F, Pouilles JM, Louvet JP. Bone mineral density and thyroid hormone therapy. Clin Endocrinol 1990; 33: 143-53.
12. Adlin EV Maurer AH, Marks AD, Channick BJ. Bone mineral density in post-menopausal women treated with L-thyroxine. Am J Med 1991; 90: 360-6.
13. Greenspan SL, Greenspan FS. Resmick NF, Block JE, Fielander AL, Genant HK. Skeletal integrity in premenopausal women and postmenopausal women receiving long-term thyroxine therapy. Am J Med 1991; 91: 4-14.
14. Diamond T, Nery L, Hales I. A therapeutic dilemma: suppressive doses of thyroxine significantly reduce bone mineral measurement in both premenopausal and post-menopausal women with thyroid carcinoma. J Clin Endocrinol Metab 1991; 72: 1184-8.
15. Taelman P, Kaufman JM, Jansenns X, Vandecauter H, Vermeulen A. Reduced forearm bone mineral content and biochemical evidence of increased bone turnover in women with euthyroid goitre treated with thyroid hormone. Clin Endocrinol 1990; 33: 107-17.
16. Marcocci C, Golia F, Bruno-Bossio G, Vignali E, Pinchera A. Carefully monitored levothyroxine suppressive therapy is not associated with bone loss in premenopausal women. J Clin Endocrinol Metab 1994; 78: 818-23.
17. Kung WC, Lorentz T, Tam SCF. Thyroxine suppressive therapy decreases bone mineral density in post-menopausal women. Clin Endocrinol 1993; 39: 535-40.
18. Wakasugi M, Wakao R, Tawata M, Gan N, Koizumi K, Onaya T. Bone mineral density in patients with hyperthyroidism measured by dual energy X-ray absorpiometry. Clin Endocrinol 1993; 38: 283-6.
19. Kraukauner JC, Kleerekoper M. Borderline-low serum thyrotropin level is correlated with increased fasting urinary hydroxyproline excretion. Arch Intern Med 1992; 152: 360-4.
20. De Los Santos ET, Storich GH, Mazzaferri EL. Sensitivity, specificity and cost-effectiveness of the sensitive thyrotropin assay in the diagnosis of thyroid disease in ambulatory patients. Arch Internal Med 1989; 149: 526-32.